Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aditxt, Inc. - Common Stock (NQ:ADTX)

1.250 +0.130 (+11.61%)
Streaming Delayed Price Updated: 1:33 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Aditxt, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Enter $10M Private Placement Agreements
Via Investor Brand Network
Aditxt Announces $10.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
From Aditxt, Inc.
Via Business Wire
Aditxt Inc. (NASDAQ: ADTX) Leading the Way in Wednesday Trading Based on Percentage Gain
Via Investor Brand Network
Aditxt Inc. (NASDAQ: ADTX) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Issues Planned Strategy for Achieving Commercial Scale, Updated Release on 1-for-40 Reverse Split
Via Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale
From Aditxt, Inc.
Via Business Wire
CORRECTING and REPLACING Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023
From Aditxt, Inc.
Via Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Effect 1-for-40 Reverse Stock Split
Via Investor Brand Network
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Pearsanta Inc. Enters LOI to Acquire Natural State Laboratories and Natural State Genomics
Via Investor Brand Network
Aditxt, Inc.’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics
From Aditxt, Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic
Via Investor Brand Network
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
From Aditxt, Inc.
Via Business Wire
Stem Cell Transplantation Shows Promise in Treating Autoimmune Disorders
Via Investor Brand Network
Organ Donation, Transplantation: Challenges and How We Can Help More Individuals
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering
Via Investor Brand Network
Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Aditxt,® Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
Via Investor Brand Network
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
Via Investor Brand Network
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Aditxt, Inc.
Via Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Inks Asset Purchase Agreement for 50% Ownership of Global Response Aid
Via Investor Brand Network
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
From Aditxt, Inc.
Via Business Wire
Allergic Reactions Caused by Gel Nail Polishes on the Rise
Via Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans
Via Investor Brand Network
Aditxt Issues Shareholder Update
From Aditxt, Inc.
Via Business Wire
US Federal Agency Plans to Overhaul Organ Transplant Network
Via Investor Brand Network
Study Describes Link Between Viral infections, Autoimmune Diseases
Via Investor Brand Network
Study Suggests Giving Babies Peanut Butter Cuts Allergy Risk
Via Investor Brand Network
Debate Rages Regarding Patients Listing on Multiple Organ Transplant Wait Lists
Via Investor Brand Network
Researchers ID Substance That Could Make Autoimmune Disease Treatment Possible
Via Investor Brand Network
How Research on Blood Cancer Could Benefit the Organ Transplant Field
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.